Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
PETX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
2.62%160.662.8%$413.11m
ZTSZoetis, Inc. Class A
0.72%84.861.9%$192.85m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.27%18.812.1%$189.44m
MYLMylan N.V.
0.14%29.593.2%$125.74m
TXMDTherapeuticsMD, Inc.
-2.48%5.1125.3%$16.16m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-0.72%37.032.0%$7.40m
TAROTaro Pharmaceutical Industries Ltd.
1.66%93.886.4%$6.66m
PETXAratana Therapeutics, Inc.
6.76%4.428.5%$5.46m
ABEOAbeona Therapeutics, Inc.
1.97%7.267.8%$3.11m
KINKindred Biosciences, Inc.
-8.03%9.850.3%$1.84m
LFVNLifeVantage Corporation
0.00%14.533.3%$1.44m
JAGXJaguar Animal Health, Inc.
3.85%0.279.8%$0.16m
CPHIChina Pharma Holdings, Inc.
-6.03%0.290.1%$0.12m

Company Profile

Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.